SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Business News | India's Healthcare, Pharma & Biotech HR Leaders Converge at Team Marksmen Network's Most Preferred Workplaces 2025-26

… Patwari, CHRO, Alembic Pharmaceuticals Limited; Dr. … Abbott India * Alembic Pharmaceuticals Ltd. * Apollo Hospitals … Enterprise Limited * CADILA PHARMACEUTICALS LIMITED * Dr. Reddy… Dhirubhai Ambani Hospital * Matrix Pharmacorp * Medtronic * P. D …

India’s stock benchmarks inch lower ahead of inflation data

Indian equity benchmarks inched lower on Tuesday as a drop in financials weighed ahead of key U.S. and domestic inflation readings. The Nifty 50 fell 0.4% to 24,487.4 points and the BSE Sensex shed 0.46% to 80,235.59. Investors await U.S. CPI data due later in the day which will guide the Federal Reserve’s rate-cut path. Lower U.S. rates typically boost the appeal of emerging market equities, including India, as yields on U.S. Treasuries fall. Eight of the 16 major sectors logged gains. The broader small-caps were flat, while mid-caps slipped 0.3%. Financials, which gained 0.9% in the previous session, reversed course and fell 1% on Tuesday. IT rose 0.4%, on the back of a U.S.-China tariff truce extension that averts triple-digit duties that is expected to shield U.S. growth, curb inflation risks, and support corporate discretionary spending, including on technology. Pharma advanced 0.7%, buoyed by strong results from Abbott India and Alkem Laboratories. The sector, like IT, counts the U.S. as a key market.

Q1 Earnings Review: HAL, Alkem, Abbott Show Strength, Balrampur Faces Mid-Year Test, Says SEBI Analyst

Equity

 Q1 earnings delivered a mixed bag, with HAL signalling a recovery, Alkem and Abbott maintaining steady growth, and Balrampur Chini facing near-term pressures

IPO-bound Corona Remedies acquires 7 brands from Bayer’s pharma division

… ’s healthcare brands from the pharmaceutical division of Bayer in India … the fourth from multinational corporations. Sanofi, GlaxoSmithKline and Abbott India were the …

India’s Pharma sector falters in H1 2025; index falls over 6% becoming the second worst-performing sector

India's pharmaceutical sector faced a 6% decline in the Nifty Pharma index in 2025, while the Nifty 50 index rose 8%. Major firms experienced significant losses, though some companies like Laurus Labs and Abbott India saw gains amid investor concerns over tariffs and macroeconomic issues.

Breakout Stocks: How to trade Nuvama Wealth, Abbott India and Max Healthcare that hit fresh 52-week high?

Indian markets extended gains for the third straight session on Thursday, with the Sensex rising over 1,000 points and Nifty50 closing above 25,500. Sectoral gains were led by energy, utilities, oil & gas, and metals, while IT and realty stocks saw some profit booking. Several breakout stocks, including Nuvama Wealth, Abbott India, and Max Healthcare, hit fresh 52-week highs.

Breakout Stocks: How to trade Avanti Feeds, Coforge and Abbott India on Thursday?

The Indian market rebounded on Wednesday, with Nifty50 gaining over 1% and Sensex surging 700+ points. Telecom, metals, power, and utilities led the rally, while breakout stocks like Avanti Feeds and Abbott India hit fresh 52-week highs.

Abbott Shares Continue To Surge, Rising By Over 12% In 2 Days After Q3 Results

The shares of the American pharma giant Abbott's Indian arm, Abbott India, surged in the intraday trade on Thursday, February 6. This was no exception, as the company carried on from where it had left. The company shares zoomed on Wednesday, February 5, as well. This surge is being attributed to the Q3 results of the company.

Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It focuses on the therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, and primary care. The company was founded on August 22, 1944 and is headquartered in Mumbai, India.

Abbott India Ltd.

Neutral Sentiment

Q1 earnings season continues to be a mixed bag.&nbsp;SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/Financialindependence">Financial Independence (FIS)</a> analyzed key earnings on August 12.&nbsp;Let’s take a look at what they had to make of stocks such as HAL, Alkem Lab, and others.&nbsp;Q1 Earnings Review&nbsp;Hindustan Aeronautics (HAL)<a href="https://stocktwits.com/symbol/HAL.NSE">HAL shares</a> fell over 1% despite steady Q1 earnings. Revenue fell 7.2% to&nbsp;₹13,700 crore, while profit fell 7.7% to ₹3,977 crore year-on-year (YoY). On a sequential basis, profit jumped 176%, signalling recovery. The company has also declared an interim dividend of ₹25/share.Orders worth ₹2.09 lakh crore (156 LCH units), ensure strong FY26 visibility, according to FIS. They said that despite YoY dips in revenue and profit, HAL’s earnings reflect a rebound in momentum thanks to a blockbuster order book and strategic dividend, which is a strong cue for growth as execution kicks in. Watch for delivery ramp-ups in Tejas and LCH to drive H2 FY26 performance.<stembedurl>https://stocktwits.com/Financialindependence/message/624718868</stembedurl>Alkem Laboratories<a href="https://stocktwits.com/symbol/ALKEM.NSE">Alkem Laboratories</a> surged 6%, driven by broader demand recovery across the healthcare segment. Its India business posted a steady performance, with profits rising 4% to ₹306 crore and revenues rising 7% to ₹3,144 crore. Operating margins remained stable at 12.5% amid cost pressures.FIS said that the company posted a stable quarter with modest growth in both topline and profitability. With cost control working well and India formulations driving volume, the business remains resilient. Recovery in exports could unlock further upside in H2.<stembedurl>https://stocktwits.com/Financialindependence/message/624717718</stembedurl>Abbott India<a href="https://stocktwits.com/symbol/ABBOTINDIA.NSE">Abbott India</a> ended subdued post its Q1 earnings print. Revenues rose 11.5% to ₹1,605 crore, while profits rose 28% to ₹367 crore.&nbsp;FIS said that Abbott India delivered a strong quarter with double-digit revenue and profit growth, underpinned by improved margins and productive cost discipline. The hefty final dividend (₹475/share) signals confidence. With consistent operating performance and strong cash flow, the outlook remains favorable into FY26.<stembedurl>https://stocktwits.com/Financialindependence/message/624717328</stembedurl>Balrampur Chini<a href="https://stocktwits.com/symbol/BALRAMCHIN.NSE">Balrampur Chini shares</a> gained 1% after the Q1 earnings report. Revenues rose 2% to ₹1,422 crore, while profits fell 5% to ₹70 crore.&nbsp;FIS noted it as a challenging quarter for Balrampur as input supply chain issues hit the sugar segment. Revenue held steady, but profitability slipped. Margin stability and improved cane availability could aid recovery. They believe that the second half looks pivotal for the stock.<stembedurl>https://stocktwits.com/Financialindependence/message/624719332</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

(Photo credit should read INDRANIL MUKHERJEE/AFP via Getty Images)

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	185.00	--	--	N/A
Q2 '25	--	195.40	--	N/A
Q1 '25	191.00	172.30	-9.79%	MISSED
Q4 '24	158.00	--	--	N/A
Q3 '24	163.00	--	--	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

ABBOTINDIA.NSE Earnings

Upcoming Earnings: Q3 '25

Historical Earnings